Macerich Reports Strong Q4 2025 Results, FFO Growth, Record Leasing, and Debt Management Success
Summary
Macerich reported strong Q4 and full-year 2025 financial results, marked by improved FFO, record leasing activity, and successful debt reduction efforts, signaling positive momentum for its strategic plan.
Key Events
-
Strong Q4 2025 Financial Performance
Net loss significantly improved to $(18.8) million, and adjusted FFO per share increased to $0.48, reflecting a positive financial trajectory.
-
Record Leasing Activity and Occupancy Gains
The company achieved a new record by signing leases for 7.1 million square feet in 2025, with portfolio occupancy at 94.0% and positive re-leasing spreads of 6.7%.
-
Successful Debt Management and Dispositions
Macerich extended a $200 million loan for South Plains Mall and completed over $1 billion in asset dispositions, significantly reducing debt and enhancing liquidity.
-
Positive Outlook on "Path Forward Plan"
Management emphasized the successful execution of its strategic plan, with a focus on completing the leasing pipeline and disciplined evaluation of new acquisition opportunities.
Analysis
The Macerich Company's fourth quarter and full-year 2025 results demonstrate significant operational improvements and successful execution of its "Path Forward Plan." The substantial reduction in net loss, coupled with increased Funds From Operations (FFO) and Net Operating Income (NOI), indicates a positive financial trajectory. Record leasing activity and consistent positive re-leasing spreads highlight strong demand for its retail spaces. Furthermore, the company's proactive debt management, including a $200 million loan extension and over $1 billion in asset dispositions, significantly de-risks the balance sheet and enhances liquidity. This report suggests a solid foundation for continued operational and financial stability.
At the time of this filing, MAC was trading at $18.77 on NYSE in the Real Estate & Construction sector, with a market capitalization of approximately $4.8B. The 52-week trading range was $12.48 to $20.88. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.